SpineThera gets a potential suitor: The maker of OxyContin
October 23, 2018 at 07:44 AM EDT
A non-opioid painkiller being developed by Plymouth-based SpineThera has caught the eye of Purdue Pharma, the maker of OxyContin, which has signed a deal to give the Connecticut pharmaceutical company the exclusive option to acquire SpineThera.
